ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Copycat Drugs Raise The Question: What’s In a Name?"
Episode Synopsis
An estimated $60 billion worth of biotechnology drugs will lose patent protection next year and the Food and Drug Administration and the government’s top consumer watchdog agency can’t seem to agree on what to name cheaper, copycat versions. That could complicate efforts to hold down medical spending.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Learn more about your ad choices. Visit megaphone.fm/adchoices
More episodes of the podcast CQ Roll Call Policy and Politics
CQ Budget: Last chance for the year
15/12/2025
CQ Budget: Defense spending uptick
08/12/2025
Political Theater: Can Congress save itself?
03/12/2025
CQ Budget: Two months to go
01/12/2025
CQ Budget: Appropriations back on track?
17/11/2025
CQ Budget: Politics of a shutdown
10/11/2025
In God we trust